After an October 1999 $750,000 seed round and a $9.0M Series A round in April 2000, this brings Vindigo’ s funding metformin hcl 850 mg tablets total to almost $16M.
Vindigo Secures $6.2M Series B
Posted by InSITE on Jul 2, 2001 in Client News, Funding Success, Media Coverage | 0 comments